Sort
23,748 grants matching “melanoma”
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$640,259John H Sampson · Duke University · P01 · FY2015 · CA
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
$640,183Cheng Zhu · Georgia Institute Of Technology · U01 · FY2021 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$640,123Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$640,123Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming
$640,056Hazem E. Ghoneim · Ohio State University · R01 · FY2025 · AI
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming
$640,056Hazem E. Ghoneim · Ohio State University · R01 · FY2023 · AI
Enhancing the Effectiveness of Immunotherapies by T Cell Epigenetic Reprogramming
$640,056Hazem E. Ghoneim · Ohio State University · R01 · FY2024 · AI
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer
$639,862Mitch A Phelps · Ohio State University · R01 · FY2022 · CA
Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment
$639,351Yubin Miao · University Of Colorado Denver · R01 · FY2023 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$639,331Robert H Vonderheide · University Of Pennsylvania · P01 · FY2022 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$639,245John H Sampson · Duke University · P01 · FY2016 · CA
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
$639,149Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2020 · CA
MICRO/NANO-IMMUNOCHIP (UIC) DEVELOPMENT AND TESTING IN MICE AND HUMANS
$639,099Owen N Witte · California Institute Of Technology · U54 · FY2009 · CA
A novel preclinical model of spontaneous metastasis
$638,924Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Tools to Analyze Morphology and Spatially Mapped Molecular Data
$638,778Joel H Saltz · State University New York Stony Brook · U24 · FY2018 · CA
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
$638,721Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · U24 · FY2015 · CA
The tumor ecosystem in cancer progression and immunotherapeutic response
$638,655Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
$638,640Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
BUILDING A COMMUNITY TO ADVANCE RESEARCH FOR PATIENTS WITH ACRAL MELANOMA
$638,621Melanoma Research Alliance Foundation · · FY2022 · Defense Health Agency
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica
$638,567Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2013 · CA
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
$638,384Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
LINKING GENETIC, METABOLIC, AND MICROENVIRONMENTAL PREDICTORS OF MELANOMA METASTATIC COLONIZATION
$638,260Rector & Visitors Of The University Of Virginia · · FY2025 · Defense Health Agency
Development of novel selective Rac inhibitors for refractory leukemias
$638,223David A Williams · Boston Children'S Hospital · R01 · FY2016 · CA
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium
$638,200Theresa A Freeman · Thomas Jefferson University · R01 · FY2025 · AR
A digital intervention to improve skin self-examination among melanoma survivors
$638,124Sharon L Manne · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA